Expert Q&As
Why does the MAH need a Pharmacien Responsable when operating in France?
Why does the MAH need a Pharmacien Responsable when operating in France?
Read moreResources
Discover a collection of resources tailored for biopharma companies looking to enter the European market.
Expert Q&As
Launching in EU – Q&A 10
How can we leverage early access programs and real-world evidence (RWE) to support our European launch?
Read more
Expert Q&As
First interactions with EMA – Q&A 3
Why is early engagement with EMA, payers, KOLs, and patient groups so important?
Read moreExpert Q&As
Launching in EU – Q&A 3
How to choose the right location for our European headquarters or hub?
Read more
Expert Q&As
Why is launching a drug in Europe different from launching in the US?
Get expert insights for the Launch of your medicine in the EU. Learn how to choose the right regulatory pathway, compare timelines, and navigate EU procedures with confidence.
Read moreExpert Q&As
What are the different regulatory pathways available when expanding to Europe and which one is the best fit for me?
What are the different regulatory pathways available when expanding to Europe and which one is the best fit for me?
Read more